![SIGA Technologies, Inc. logo](/logos/SIGA.webp)
SIGA Technologies, Inc.
NASDAQ:SIGA
Overview | Financials
Company Name | SIGA Technologies, Inc. |
Symbol | SIGA |
Currency | USD |
Price | 7.71 |
Market Cap | 550,257,303 |
Dividend Yield | 7.64% |
52-week-range | 4.22 - 12.83 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Phillip Louis Gomez III, M.D., Ph.D. |
Website | https://www.siga.com |
An error occurred while fetching data.
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD